Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.

Clinical trial NCT04069689 · COMPLETED

Trial details

NCT number: NCT04069689
Sponsor: Epygenix
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dravet Syndrome

Start date: 2019-08-29
Primary completion: 2019-11-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.